2018
Phthalate Metabolites and Postmenopausal Breast Cancer Risk
Reeves K, Diaz S, Hankinson, Bigelow C, Zoeller, Manson J, Spiegelman D, Tinker L. Phthalate Metabolites and Postmenopausal Breast Cancer Risk. Cancer Epidemiology Biomarkers & Prevention 2018, 27: 355-355. DOI: 10.1158/1055-9965.epi-18-0052.Peer-Reviewed Original ResearchBreast cancer riskPhthalate metabolitesCancer riskWomen’s Health Initiative prospective cohortMultivariable conditional logistic regression analysisConditional logistic regression analysisHuman breast cancer riskIndividual phthalate metabolitesBody mass indexMono-2-ethylhexyl phthalateAnimal model evidenceCase-control studyHuman breast milkLogistic regression analysisRace/ethnicityProspective cohortSmoking statusEnrollment dateMass indexBreast milkProspective dataRisk ratioStudy groupMonoethyl phthalateResults Overall
2001
Do HIV Type 1 RNA Levels Provide Additional Prognostic Value to CD4+ T Lymphocyte Counts in Patients with Advanced HIV Type 1 Infection?
Arduino J, Fischl M, Stanley K, Collier A, Spiegelman D. Do HIV Type 1 RNA Levels Provide Additional Prognostic Value to CD4+ T Lymphocyte Counts in Patients with Advanced HIV Type 1 Infection? AIDS Research And Human Retroviruses 2001, 17: 1099-1105. PMID: 11522179, DOI: 10.1089/088922201316912709.Peer-Reviewed Original ResearchConceptsHIV-1 RNA levelsHIV-1 disease progressionBaseline HIV-1 RNA levelsT-lymphocyte countsT lymphocytesDisease progressionLymphocyte countRNA levelsCells/Prognostic informationHigh baseline HIV-1 RNA levelsHIV type 1 RNA levelsPlasma HIV-1 RNA levelsSubsequent HIV-1 disease progressionAdvanced HIV-1 diseaseHIV Type 1 InfectionConditional logistic regression analysisDisease progression independentHIV-1 diseaseAdditional prognostic informationAdditional prognostic valueType 1 infectionCase-control studyLogistic regression analysisClinical status